Reconciliation of Stockholders' (Deficit) Equity (Unaudited) - USD ($)	Common Stock	Additional Paid-in Capital	Accumulated Deficit	Equity Attributable to Internat’l Isotopes Shareholders	Total	Equity Attributable to Noncontrolling Interest
Beginning balance, value at Dec. 31, 2020	$ 4,243,443	$ 122,191,837	$ (125,861,734)	$ 573,546	$ 2,887,252	$ 2,313,706
Shares outstanding at Dec. 31, 2020	424,344,298
Shares issued under employee stock purchase plan	$ 2,561	10,966		13,527	13,527
Shares issued under employee stock purchase plan, shares	256,079
Stock grant	$ 1,183	(1,183)
Stock grant, shares	118,315
Stock in lieu of dividends on convertible preferred C	$ 13,982	193,498		207,480	207,480
Stock in lieu of dividends on convertible preferred C, shares	1,398,200
Shares issued for exercise of employee stock options	$ 19,082	(19,082)
Shares issued for exercise of employee stock options, shares	1,908,198
Warrant exercise	$ 326,214	(326,214)
Warrant exercises, shares	32,621,409
Conversion of preferred B stock	$ 875	174,125		175,000	175,000
Conversion of preferred B stock, shares	87,500
Stock based compensation		60,671		60,671	60,671
Net (loss) income			(919,408)	(919,408)	(806,021)	113,387
Conversion of preferred C stock	$ 15,000	135,000		150,000	150,000
Conversion of preferred C stock, shares	1,500,000
Shares issued for purchase of 75.5% of RadQual	$ 401,762	2,021,900		2,423,662		(2,423,662)
Shares issued for purchase of 75.5% of RadQual, shares	40,176,236
Distribution to non-controlling interest					(3,431)	(3,431)
Ending balance, value at Sep. 30, 2021	$ 5,024,102	124,441,518	(126,781,142)	2,684,478	2,684,478
Shares outstanding at Sep. 30, 2021	502,410,235
Beginning balance, value at Jun. 30, 2021	$ 4,608,305	122,292,543	(126,644,273)	256,575	2,682,824	2,426,249
Shares outstanding at Jun. 30, 2021	460,830,469
Shares issued under employee stock purchase plan	$ 444	4,088		4,532	4,532
Shares issued under employee stock purchase plan, shares	44,439
Shares issued for exercise of employee stock options	$ 1,091	(1,091)
Shares issued for exercise of employee stock options, shares	109,091
Stock based compensation		11,578		11,578	11,578
Net (loss) income			(136,869)	(136,869)	(136,025)	844
Conversion of preferred C stock	$ 12,500	112,500		125,000	125,000
Conversion of preferred C stock, shares	1,250,000
Shares issued for purchase of 75.5% of RadQual	$ 401,762	2,021,900		2,423,662		(2,423,662)
Shares issued for purchase of 75.5% of RadQual, shares	40,176,236
Distribution to non-controlling interest					(3,431)	(3,431)
Ending balance, value at Sep. 30, 2021	$ 5,024,102	124,441,518	(126,781,142)	2,684,478	2,684,478
Shares outstanding at Sep. 30, 2021	502,410,235
Beginning balance, value at Dec. 31, 2021	$ 5,025,842	124,469,034	(126,764,081)	2,730,795	2,730,795
Shares outstanding at Dec. 31, 2021	502,584,176
Shares issued under employee stock purchase plan	$ 1,726	10,579		12,305	12,305
Shares issued under employee stock purchase plan, shares	172,534
Stock grant	$ 1,872	(1,872)
Stock grant, shares	187,231
Stock in lieu of dividends on convertible preferred C	$ 22,720	181,760		204,480	204,480
Stock in lieu of dividends on convertible preferred C, shares	2,271,980
Shares issued for exercise of employee stock options	$ 6,489	(6,489)
Shares issued for exercise of employee stock options, shares	648,948				1,200,000
Warrant exercise	$ 5,150	56,650		61,800	$ 61,800
Warrant exercises, shares	515,000
Conversion of preferred B stock	$ 84,375	590,625		675,000	675,000
Conversion of preferred B stock, shares	8,437,500
Stock based compensation		297,243		297,243	297,243
Net (loss) income			414,328	414,328	414,328
Distribution to non-controlling interest
Ending balance, value at Sep. 30, 2022	$ 5,148,174	125,597,530	(126,349,753)	4,395,951	4,395,951
Shares outstanding at Sep. 30, 2022	514,817,369
Beginning balance, value at Jun. 30, 2022	$ 5,147,269	125,535,534	(125,781,084)	4,901,719	4,901,719
Shares outstanding at Jun. 30, 2022	514,726,908
Shares issued under employee stock purchase plan	$ 527	2,605		3,132	3,132
Shares issued under employee stock purchase plan, shares	52,624
Shares issued for exercise of employee stock options	$ 378	(378)
Shares issued for exercise of employee stock options, shares	37,837
Stock based compensation		59,769		59,769	59,769
Net (loss) income			(568,669)	(568,669)	(568,669)
Ending balance, value at Sep. 30, 2022	$ 5,148,174	$ 125,597,530	$ (126,349,753)	$ 4,395,951	$ 4,395,951
Shares outstanding at Sep. 30, 2022	514,817,369